19 natural-products research jobs at Center for Drug Evaluation and Research (CDER) in United States
-
Center for Drug Evaluation and Research (CDER) | Silver Spring, Maryland | United States | about 14 hours ago
the Office of New Drugs/ Office of Rare Diseases, Pediatrics, Urologic and Reproductive Medicine (ORPURM), located in Silver Spring, Maryland. CDER performs an essential public health task by making sure that
-
Center for Drug Evaluation and Research (CDER) | Saint Louis, Missouri | United States | about 14 hours ago
. This complexity arises from diverse chemical modifications aimed at enhancing the stability, efficacy, and safety of these products. Consequently, there is a pressing need to enhance the resolution of conventional
-
Center for Drug Evaluation and Research (CDER) | Silver Spring, Maryland | United States | about 14 hours ago
Research (CDER), located at Silver Spring, Maryland. This project is located in the Office of Pharmacovigilance & Epidemiology (OPE), Office of Surveillance and Epidemiology (OSE). Research Project
-
Center for Drug Evaluation and Research (CDER) | Silver Spring, Maryland | United States | about 14 hours ago
Research (CDER), located at Silver Spring, Maryland. This project is located in the Office of Pharmacovigilance & Epidemiology (OPE), Office of Surveillance and Epidemiology (OSE). The Center for Drug
-
Center for Drug Evaluation and Research (CDER) | Silver Spring, Maryland | United States | about 14 hours ago
cover the best practices in drug and biological product post-market safety surveillance. The participant will be trained to retrieve information needed for the research project from FDA databases (e.g
-
Center for Drug Evaluation and Research (CDER) | Silver Spring, Maryland | United States | about 14 hours ago
of anti-infective drug products currently approved for pediatric use. How to prepare a database capturing study design and PK results. Population PK and probability of target attainment (PTA) analyses
-
Center for Drug Evaluation and Research (CDER) | Saint Louis, Missouri | United States | 23 days ago
involved in the development of analytical procedures to characterize adulterants in drug products using Nuclear Resonance Magnetic Resonance (NMR) spectroscopy. Using the developed method, you will screen a
-
the FDA, DMEPA I & II review and are the regulatory signatures for proprietary names for CDER regulated drug products. DMEPA I & II also spend resources tracking Pending Name Conflicts (PNCs) as a part of
-
Center for Drug Evaluation and Research (CDER) | Saint Louis, Missouri | United States | about 14 hours ago
characterization and quantification of opioid drug products. The project will involve development of sample preparation procedures utilizing an automated dissolution testing system, characterization